tirzepatide treatment services Miami Injections For Weight Loss – Doctor‑Led GLP‑1/GIP Care Tirzepatide Therapy in Coral Gables

After the initial 36 weeks, participants lost 21.1% of their body weight After the following 52 weeks, the tirzepatide group lost another 6.7% of their body weight, while the placebo group regained 14.8% Through the 88-week study, the tirzepatide group lost 26% of their body weight Tirzepatide had a similar safety profile in SURMOUNT-3 and SURMOUNT-4 as its previous trials, most commonly citing mild-moderate gastrointestinal issues

Compounded meds without proof of accreditation or sterile standards are a red flag

Conclusion Heres the thing, affordability and safety can both matter

Access to GLP1 medication, when prescribed after your evaluation, with dose adjusted over time based on your response, tolerability, and clinical judgment

Contrave combines naltrexone and bupropion, and neither is classified as a stimulant medication

At that point you only need to come in every 3 months for office visits